Antonio Valero1, Paula Ribó1, Luis Maíz2, Esther Barbero2, Myriam Calle3, Carlos Campo4, Paula Rytilä5, Jordi Giner6, Vicente Plaza6. 1. a Servicio de Neumología y Alergia, Hospital Clínic. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Centro de Investigaciones Biomédicas en Red de Enfermedades Respiratorias (CIBERES) , Barcelona , Spain. 2. b Pneumology Department , Hospital Ramón y Cajal , Madrid , Spain. 3. c Pulmonary Departament, Hospital Clínico San Carlos, Departament of Medicine, Faculty of Medicine , University Complutense of Madrid, Institute of Investigació Biomédica of Hospital Clínico San Carlos (IdISSC) , Madrid , Spain. 4. d Orion Pharma , Madrid , Spain. 5. e Orion Corporation Orion Pharma , Espoo , Finland. 6. f Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau. Institut d'Investigació Biomédica Sant Pau (IIB Sant Pau) , Centro de Investigaciones Biomédicas en Red de Enfermedades Respiratorias (CIBERES), Universitat Autònoma de Barcelona, Department of Medicine , Barcelona , Spain.
Abstract
BACKGROUND: The preferences and opinions of patients are important when choosing the optimal inhaler device for asthma management. We compared patient satisfaction of three dry powder inhalers in patients with moderate to severe asthma. METHODS: We selected a group of patients treated with EasyhalerTM (n = 164) and a second group of patients treated with TurbuhalerTM (n = 100) or DiskusTM (AccuhalerTM) (n = 64) from the register of an observational, multicenter study. Data of patients were paired according to age, gender, and asthma severity. Patient satisfaction with the inhaler type was assessed with the specific 'Feeling of Satisfaction with Inhaler' (FSI-10) questionnaire. RESULTS: Specific satisfaction with inhaler was statistically significantly higher with EasyhalerTM, as well as the percentage of patients with high satisfaction with inhaler. (FSI-10 score ≥43). Scores for EasyhalerTM were also statistically significantly better for individual FSI-10 items such as learning how to use, inhaler preparation, inhaler use, weight and size, and portability. There were no significant differences in asthma control (ACT, Mini-AQLQ) and adherence (TAI global score). CONCLUSIONS: Specific satisfaction with inhaler was higher with EasyhalerTM in a homogeneous population of patients with moderate to severe asthma. However, the relationship between satisfaction with the inhaler and adherence and asthma control deserves more investigation.
BACKGROUND: The preferences and opinions of patients are important when choosing the optimal inhaler device for asthma management. We compared patient satisfaction of three dry powder inhalers in patients with moderate to severe asthma. METHODS: We selected a group of patients treated with EasyhalerTM (n = 164) and a second group of patients treated with TurbuhalerTM (n = 100) or DiskusTM (AccuhalerTM) (n = 64) from the register of an observational, multicenter study. Data of patients were paired according to age, gender, and asthma severity. Patient satisfaction with the inhaler type was assessed with the specific 'Feeling of Satisfaction with Inhaler' (FSI-10) questionnaire. RESULTS: Specific satisfaction with inhaler was statistically significantly higher with EasyhalerTM, as well as the percentage of patients with high satisfaction with inhaler. (FSI-10 score ≥43). Scores for EasyhalerTM were also statistically significantly better for individual FSI-10 items such as learning how to use, inhaler preparation, inhaler use, weight and size, and portability. There were no significant differences in asthma control (ACT, Mini-AQLQ) and adherence (TAI global score). CONCLUSIONS: Specific satisfaction with inhaler was higher with EasyhalerTM in a homogeneous population of patients with moderate to severe asthma. However, the relationship between satisfaction with the inhaler and adherence and asthma control deserves more investigation.
Authors: Mark L Levy; Will Carroll; José L Izquierdo Alonso; Claus Keller; Federico Lavorini; Lauri Lehtimäki Journal: Adv Ther Date: 2019-09-02 Impact factor: 3.845
Authors: Paula Ribó; Jesús Molina; Myriam Calle; Luis Maiz; Carlos Campo; Paula Rytilä; Vicente Plaza; Antonio Valero Journal: NPJ Prim Care Respir Med Date: 2020-07-31 Impact factor: 2.871
Authors: Francisco Javier Alvarez-Gutiérrez; Ana Gómez-Bastero Fernández; Juan Francisco Medina Gallardo; Carlos Campo Sien; Paula Rytilä; Julio Delgado Romero Journal: Patient Prefer Adherence Date: 2021-02-16 Impact factor: 2.711